Comparing persistence of new biologics to conventional anti-TNF alphas in adult patients with inflammatory bowel disease: a systematic review and meta-analysis protocol

BACKGROUND: Biological therapy is a cornerstone of managing moderate-to-severe inflammatory bowel disease (IBD), ulcerative colitis (UC) and Crohn’s disease (CD). New biologics have been evolving over the past 20 years and selection of an agent remains challenging. Drug persistence measures the dura...

Descripción completa

Detalles Bibliográficos
Autores principales: Yiu, Tsz Hong, Ko, Yanna, Pudipeddi, Aviv, Natale, Patrizia, Leong, Rupert W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Gastroenterology and Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551959/
https://www.ncbi.nlm.nih.gov/pubmed/37788929
http://dx.doi.org/10.1136/bmjopen-2023-073071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551959/
https://www.ncbi.nlm.nih.gov/pubmed/37788929
http://dx.doi.org/10.1136/bmjopen-2023-073071

Ejemplares similares